Treatment Cycle 16 - Day 1

Dr. Hurvitz told us today that the results of our study will be published next June, and that she'll be able to share the preliminary results with us next January after the last trial patient (#444) has her surgery. If the Arm B (test) patients have equivalent or better outcomes than Arm A (control) patients, Roche will probably then submit to the FDA for approval of TDM-1 for early-stage patients. I will be so excited if this treatment becomes available to everyone - the amount of suffering that would be avoided blows my mind. 16 down, two to go!